Skip to main content

Neil Osheroff Archives

Novel drugs have potential for treating tuberculosis

Apr. 24, 2023—Drug-resistant tuberculosis is on the rise, and novel antibacterial drugs called SPTs have potential for treating the deadly lung infection.

Read more


Study explores new urinary tract infection treatment

Feb. 2, 2023—Vanderbilt's Neil Osheroff, PhD, is part of an international research collaboration resulting in what is on track to be the first new antibiotic treatment for uncomplicated urinary tract infections in more than 20 years.

Read more


Capacity building activities and new curriculum strengthen medical education in Liberia

Feb. 24, 2022—Liberia's fragile health system is being strengthened through U.S.-Liberia partnerships focused on medical education and capacity building at the country's only medical school, A.M. Dogliotti (AMD) School of Medicine in the College of Health Sciences at the University of Liberia.

Read more


Osheroff elected to AAMC council leadership post

Jul. 22, 2021—Neil Osheroff, PhD, professor of Biochemistry and Medicine, has been elected to a leadership position for a council of the Association of American Medical Colleges (AAMC).

Read more


Osheroff elected IAMSE president

Dec. 12, 2019—Neil Osheroff, PhD, was elected president of the International Association of Medical Science Educators (IAMSE) and will serve from January 2020-December 2021.

Read more


International Association of Medical Science Educators honors Osheroff

Jul. 8, 2019—Neil Osheroff, PhD, John G. Coniglio professor of Biochemistry, professor of Medicine and director of the Academy for Excellence in Education, received the Distinguished Career Award for Excellence in Teaching and Educational Scholarship from the International Association of Medical Science Educators (IAMSE).

Read more


A new antibiotic’s mechanism of action

Apr. 25, 2019—Vanderbilt investigators have characterized how a new first-in-class antibacterial drug works, which will guide the development of additional compounds that overcome antibacterial resistance.

Read more


Correctly copying DNA

Mar. 14, 2019—A precise understanding of how the enzyme topoisomerase II cuts DNA could lead to better anti-cancer therapies.

Read more


Five faculty elected AAAS fellows

Nov. 29, 2018—Five Vanderbilt University faculty members have been elected fellows of the American Association for the Advancement of Science this year.

Read more


Confronting TB resistance

Jun. 11, 2018—Vanderbilt researchers describe how certain tuberculosis treatments work and suggest these medications may overcome the threat of drug-resistant tuberculosis.

Read more


Self care, mindfulness key to decreasing burnout: speaker

Apr. 26, 2018—It’s not often that a keynote speaker will ask his audience to close their eyes and tune him out, but that’s what Aviad “Adi” Haramati, PhD, did when delivering the 2018 John E. Chapman Lecture.

Read more


Novel insights to antibiotic targets

Sep. 29, 2017—New mechanistic details about the DNA-unwinding activity of antibacterial protein targets could lead to the design of better antibiotic medicines.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more